Company intelligence / Profile preview

Takara Bio USA

San Jose, California, United States

Ownership: Private
Employees: ~217
Development stage: Other

Overview

Takara Bio USA is a leading provider of kits, reagents, and instruments for gene discovery and cell/gene therapy R&D. Its products are commercial stage and primarily support research rather than direct clinical programs.

Modalities: Recombinant proteinCell therapyGene therapySmall moleculemRNA-based drugsEnzyme replacement therapy
Industry: Non-Drug Biotech

Partnerships

Jumpcode Genomics (global patent partnership)

Beyond the preview

Go deeper on Takara Bio USA.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Takara Bio USA.

Explore the full profile